IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez, P. F.
Right arrow Articles by Hinton, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez, P. F.
Right arrow Articles by Hinton, D. R.

Investigative Ophthalmology & Visual Science, Vol 37, 855-868, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age- related macular degeneration-related choroidal neovascular membranes

PF Lopez, BD Sippy, HM Lambert, AB Thach and DR Hinton
Department of Ophthalmology, University of Southern California, Los Angeles, CA 90033, USA.

PURPOSE: To determine the cellular origin and the vascular endothelial growth factor (VEGF) immunoreactivity of the nonvascular stromal cells in surgically excised age-related macular degeneration (ARMD)- associated choroidal neovascular membranes (CNVMs). METHODS: Immunohistochemical analysis was performed on frozen sections of eight surgically excised ARMD-related CNVMs. RESULTS: Cytokeratin-positive, smooth muscle actin-positive polygonal or fibroblastic (transdifferentiated RPE) cells were the principal nonvascular stromal cells detected. The polygonal cells were more commonly found in active (highly vascularized) regions and were strongly immunoreactive for VEGF. The fibroblastic cells were predominantly found in fibrotic (hypovascular) regions and were minimally immunoreactive for VEGF. CONCLUSIONS: Transdifferentiated RPE cells are the principal nonvascular stromal cells of both vascular and fibrotic ARMD-related CNVMs. Preferential localization of VEGF immunoreactivity with the cytoplasm of the polygonal transdifferentiated RPE cells in the highly vascularized regions of the surgically excised CNVMs suggests an important angiogenic role of these cells and this growth factor in the progression of ARMD-related choroidal neovascularization.


This article has been cited by other articles:


Home page
 IOVSHome page
S. Kaempf, S. Johnen, A. K. Salz, A. Weinberger, P. Walter, and G. Thumann
Effects of Bevacizumab (Avastin) on Retinal Cells in Organotypic Culture
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3164 - 3171.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. A. Economou, J. Wu, D. Vasilcanu, L. Rosengren, C. All-Ericsson, I. van der Ploeg, E. Menu, L. Girnita, M. Axelson, O. Larsson, et al.
Inhibition of VEGF Secretion and Experimental Choroidal Neovascularization by Picropodophyllin (PPP), an Inhibitor of the Insulin-like Growth Factor-1 Receptor
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2620 - 2626.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, A. Adam, K. Shinoda, C. Eckardt, V. Boeyden, C. Claes, G. Pertile, et al.
Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization
Arch Ophthalmol, June 1, 2008; 126(6): 782 - 790.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Campa, I. Kasman, W. Ye, W. P. Lee, G. Fuh, and N. Ferrara
Effects of an Anti-VEGF-A Monoclonal Antibody on Laser-Induced Choroidal Neovascularization in Mice: Optimizing Methods to Quantify Vascular Changes
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1178 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y.-Z. Le, W. Zheng, P.-C. Rao, L. Zheng, R. E. Anderson, N. Esumi, D. J. Zack, and M. Zhu
Inducible Expression of Cre Recombinase in the Retinal Pigmented Epithelium
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1248 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Yu, X. Wu, Z. Cheng, C. V. Lee, J. LeCouter, C. Campa, G. Fuh, H. Lowman, and N. Ferrara
Interaction between Bevacizumab and Murine VEGF-A: A Reassessment
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 522 - 527.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Ju, C. Mailhos, J. Bradley, T. Dowie, M. Ganley, G. Cook, P. Calias, N. Lange, A. P. Adamis, D. T. Shima, et al.
Simultaneous but Not Prior Inhibition of VEGF165 Enhances the Efficacy of Photodynamic Therapy in Multiple Models of Ocular Neovascularization
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 662 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti
Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
U. Schmidt-Erfurth, M. Rudolf, M. Funk, C. Hofmann-Rummelt, N.-S. Franz-Haas, Z. Aherrahrou, and U. Schlotzer-Schrehardt
Ultrastructural Changes in a Murine Model of Graded Bruch Membrane Lipoidal Degeneration and Corresponding VEGF164 Detection
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 390 - 398.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Matsubara, T. Nakazawa, K. Noda, H. She, E. Connolly, T. A. Young, Y. Ogura, E. S. Gragoudas, and J. W. Miller
Photodynamic Therapy Induces Caspase-Dependent Apoptosis in Rat CNV Model
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4741 - 4747.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M. Bolz, S. Michels, W. Geitzenauer, F. Prager, and U. Schmidt-Erfurth
Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment
Br. J. Ophthalmol., June 1, 2007; 91(6): 785 - 789.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
S K Gibran, A Sachdev, T Stappler, R Newsome, D Wong, and P Hiscott
Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)
Br. J. Ophthalmol., May 1, 2007; 91(5): 602 - 604.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M.-F. Zuluaga, C. Mailhos, G. Robinson, D. T. Shima, R. Gurny, and N. Lange
Synergies of VEGF Inhibition and Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1767 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
U. U. Inan, B. Avci, T. Kusbeci, B. Kaderli, R. Avci, and S. G. Temel
Preclinical Safety Evaluation of Intravitreal Injection of Full-Length Humanized Vascular Endothelial Growth Factor Antibody in Rabbit Eyes
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1773 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R Obata, A Iriyama, Y Inoue, H Takahashi, Y Tamaki, and Y Yanagi
Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro
Br. J. Ophthalmol., January 1, 2007; 91(1): 100 - 104.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, R. Y. Kim, and the MARINA Study Group
Ranibizumab for Neovascular Age-Related Macular Degeneration
N. Engl. J. Med., October 5, 2006; 355(14): 1419 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
E. W.M NG and A. P ADAMIS
Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
Ann. N.Y. Acad. Sci., October 1, 2006; 1082(1): 151 - 171.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. A. Costa, R. Jorge, D. Calucci, J. A. Cardillo, L. A. S. Melo Jr, and I. U. Scott
Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation Study.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4569 - 4578.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M S Spitzer, B Wallenfels-Thilo, A Sierra, E Yoeruek, S Peters, S Henke-Fahle, K U Bartz-Schmidt, P Szurman, and on behalf of the Tuebingen Bevacizumab Study Group
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells
Br. J. Ophthalmol., October 1, 2006; 90(10): 1316 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. M. Cashman, L. Bowman, J. Christofferson, and R. Kumar-Singh
Inhibition of Choroidal Neovascularization by Adenovirus-Mediated Delivery of Short Hairpin RNAs Targeting VEGF as a Potential Therapy for AMD.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3496 - 3504.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization
FASEB J, August 1, 2006; 20(10): 1689 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
B Zhao, A Ma, J Cai, and M Boulton
VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells
Br. J. Ophthalmol., August 1, 2006; 90(8): 1052 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
I A Bhutto, D S McLeod, C Merges, T Hasegawa, and G A Lutty
Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration
Br. J. Ophthalmol., July 1, 2006; 90(7): 906 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, E. Kaiserling, A. Adam, F. Gelisken, K. Shinoda, M. Volker, B. A. Lafaut, K. U. Bartz-Schmidt, and S. Grisanti
Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Arch Ophthalmol, June 1, 2006; 124(6): 815 - 823.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Nozaki, B. J. Raisler, E. Sakurai, J. V. Sarma, S. R. Barnum, J. D. Lambris, Y. Chen, K. Zhang, B. K. Ambati, J. Z. Baffi, et al.
Drusen complement components C3a and C5a promote choroidal neovascularization
PNAS, February 14, 2006; 103(7): 2328 - 2333.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
I. K. Kim, D. Husain, N. Michaud, E. Connolly, A. M. Lane, K. Durrani, A. Hafezi-Moghadam, E. S. Gragoudas, C. A. O'Neill, J. C. Beyer, et al.
Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. He, Y. Ding, J. Zhou, V. Krasnoperov, S. Zozulya, S. R. Kumar, S. J. Ryan, P. S. Gill, and D. R. Hinton
Soluble EphB4 Regulates Choroidal Endothelial Cell Function and Inhibits Laser-Induced Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4772 - 4779.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
F. Bottoni, A. Massacesi, M. Cigada, F. Viola, I. Musicco, and G. Staurenghi
Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration: A Series of 104 Cases of Retinal Angiomatous Proliferation
Arch Ophthalmol, December 1, 2005; 123(12): 1644 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. N. Roybal, L. Y. Marmorstein, D. L. Vander Jagt, and S. F. Abcouwer
Aberrant Accumulation of Fibulin-3 in the Endoplasmic Reticulum Leads to Activation of the Unfolded Protein Response and VEGF Expression
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3973 - 3979.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
O. Strauss
The Retinal Pigment Epithelium in Visual Function
Physiol Rev, July 1, 2005; 85(3): 845 - 881.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. N. Roybal, L. A. Hunsaker, O. Barbash, D. L. V. Jagt, and S. F. Abcouwer
The Oxidative Stressor Arsenite Activates Vascular Endothelial Growth Factor mRNA Transcription by an ATF4-dependent Mechanism
J. Biol. Chem., May 27, 2005; 280(21): 20331 - 20339.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. V. Miceli and S. M. Jazwinski
Nuclear Gene Expression Changes Due to Mitochondrial Dysfunction in ARPE-19 Cells: Implications for Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1765 - 1773.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Gaudreault, D. Fei, J. Rusit, P. Suboc, and V. Shiu
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 726 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. G. Slomiany and S. A. Rosenzweig
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C746 - C753.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ferrara
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Endocr. Rev., August 1, 2004; 25(4): 581 - 611.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. G. Slomiany and S. A. Rosenzweig
IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M Matsuoka, N Ogata, T Otsuji, T Nishimura, K Takahashi, and M Matsumura
Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy
Br. J. Ophthalmol., June 1, 2004; 88(6): 809 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. A. Zarbin
Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
Arch Ophthalmol, April 1, 2004; 122(4): 598 - 614.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. J. Koh, K. Bessho, L. Cheng, D.-U. Bartsch, T. R. Jones, G. Bergeron-Lynn, and W. R. Freeman
Inhibition of Choroidal Neovascularization in Rats by the Urokinase-Derived Peptide A6
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 635 - 640.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. Tomita, H. Yamada, Y. Adachi, Y. Cui, E. Yamada, A. Higuchi, K. Minamino, Y. Suzuki, M. Matsumura, and S. Ikehara
Choroidal Neovascularization Is Provided by Bone Marrow Cells
Stem Cells, January 1, 2004; 22(1): 21 - 26.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. G. Espinosa-Heidmann, A. Caicedo, E. P. Hernandez, K. G. Csaky, and S. W. Cousins
Bone Marrow-Derived Progenitor Cells Contribute to Experimental Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4914 - 4919.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Saishin, R. L. Silva, Y. Saishin, K. Callahan, C. Schoch, M. Ahlheim, H. Lai, F. Kane, R. K. Brazzell, D. Bodmer, et al.
Periocular Injection of Microspheres Containing PKC412 Inhibits Choroidal Neovascularization in a Porcine Model
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4989 - 4993.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann
Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
S. He, M. L. Jin, V. Worpel, and D. R. Hinton
A Role for Connective Tissue Growth Factor in the Pathogenesis of Choroidal Neovascularization
Arch Ophthalmol, September 1, 2003; 121(9): 1283 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
G McGwin Jr, C Owsley, C A Curcio, and R J Crain
The association between statin use and age related maculopathy
Br. J. Ophthalmol., September 1, 2003; 87(9): 1121 - 1125.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
T A Ciulla, M H Criswell, R P Danis, M Fronheiser, P Yuan, T A Cox, K G Csaky, and M R Robinson
Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants
Br. J. Ophthalmol., August 1, 2003; 87(8): 1032 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
F. Wang, K. G. Rendahl, W. C. Manning, D. Quiroz, M. Coyne, and S. S. Miller
AAV-Mediated Expression of Vascular Endothelial Growth Factor Induces Choroidal Neovascularization in Rat
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 781 - 790.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Malek, C.-M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio
Apolipoprotein B in Cholesterol-Containing Drusen and Basal Deposits of Human Eyes with Age-Related Maculopathy
Am. J. Pathol., February 1, 2003; 162(2): 413 - 425.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Berglin, S. Sarman, I. van der Ploeg, B. Steen, Y. Ming, S. Itohara, S. Seregard, and A. Kvanta
Reduced Choroidal Neovascular Membrane Formation in Matrix Metalloproteinase-2-Deficient Mice
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. Ogata, M. Wada, T. Otsuji, N. Jo, J. Tombran-Tink, and M. Matsumura
Expression of Pigment Epithelium-Derived Factor in Normal Adult Rat Eye and Experimental Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1168 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. G. Krzystolik, M. A. Afshari, A. P. Adamis, J. Gaudreault, E. S. Gragoudas, N. A. Michaud, W. Li, E. Connolly, C. A. O'Neill, and J. W. Miller
Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti-Vascular Endothelial Growth Factor Antibody Fragment
Arch Ophthalmol, March 1, 2002; 120(3): 338 - 346.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Guidry, N. E. Medeiros, and C. A. Curcio
Phenotypic Variation of Retinal Pigment Epithelium in Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 267 - 273.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C.-C. Lai, W.-C. Wu, S.-L. Chen, X. Xiao, T.-C. Tsai, S.-J. Huan, T.-L. Chen, R. J.-F. Tsai, and Y.-P. Tsao
Suppression of Choroidal Neovascularization by Adeno-associated Virus Vector Expressing Angiostatin
Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2401 - 2407.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Hangai, T. Murata, N. Miyawaki, C. Spee, J. I. Lim, S. He, D. R. Hinton, and S. J. Ryan
Angiopoietin-1 Upregulation by Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1617 - 1625.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
N. Ferrara
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1358 - C1366.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
T. A. Ciulla, M. H. Criswell, R. P. Danis, and T. E. Hill
Intravitreal Triamcinolone Acetonide Inhibits Choroidal Neovascularization in a Laser-Treated Rat Model
Arch Ophthalmol, March 1, 2001; 119(3): 399 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Schwesinger, C. Yee, R. M. Rohan, A. M. Joussen, A. Fernandez, T. N. Meyer, V. Poulaki, J. J. K. Ma, T. M. Redmond, S. Liu, et al.
Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium
Am. J. Pathol., March 1, 2001; 158(3): 1161 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. J. Crane, C. A. Wallace, S. McKillop-Smith, and J. V. Forrester
CXCR4 Receptor Expression on Human Retinal Pigment Epithelial Cells from the Blood-Retina Barrier Leads to Chemokine Secretion and Migration in Response to Stromal Cell-Derived Factor 1{alpha}
J. Immunol., October 15, 2000; 165(8): 4372 - 4378.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Baffi, G. Byrnes, C.-C. Chan, and K. G. Csaky
Choroidal Neovascularization in the Rat Induced by Adenovirus Mediated Expression of Vascular Endothelial Growth Factor
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3582 - 3589.
[Abstract] [Full Text]

Home page
 IOVSHome page
N. Kwak, N. Okamoto, J. M. Wood, and P. A. Campochiaro
VEGF Is Major Stimulator in Model of Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3158 - 3164.
[Abstract] [Full Text]